drugset

drugset / Trial / NCT02158572

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

NCT02158572 ↗

Phase 3 Completed 2032 enrolled Agile Therapeutics

NaSingle-groupOpen-labelTreatment

Summary

Study of the efficacy of a contraceptive patch in 2100 healthy women for up to one year.

Timeline

Start: 2014-08
Primary completion: 2016-11
Completion: 2016-11

Publications

Nelson AL, Kaunitz AM, Kroll R, Simon JA, Poindexter AN, Castano PM, Ackerman RT, Flood L, Chiodo JA 3rd, Garner EI; SECURE Investigators. Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results. Contraception. 2021 Mar;103(3):137-143. doi: 10.1016/j.contraception.2020.11.011. Epub 2020 Nov 28.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levonorgestrel	Small molecule	120 ug	Other
Subject	ethinyl estradiol	Small molecule	30 ug	Other

Indications

No indication recorded.